| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_4b3db7dd56b56cc6d94d0e0cccc38322 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K8-4973
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K8-4926
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K8-494
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P17-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P17-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61Q19-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-454
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-44
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-415
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-343 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K8-49
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-343
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-415
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61Q19-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P17-00 |
| filingDate |
2012-08-03^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_a6a382cc739a28ef859ae887ddcff636
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_767c25be972f03d7cb7c4e6ea232c6ae
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_ae3a28d926cd1e36fd0b8551eb4c623e
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_fb92f042f4814662b5d0601e18bd39fd |
| publicationDate |
2014-06-09^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
KR-20140068934-A |
| titleOfInvention |
Use of a cb1 receptor antagonist as a whitening and/or anti-browning agent for keratin material |
| abstract |
The present invention relates to non-therapeutic cosmetic uses of at least one CB1 receptor antagonist as a whitening agent for keratinous materials and / or as a browning agent. The present invention also relates to CB1 receptor antagonists used in the treatment of hypercholesterolemia. The present invention further relates to a non-therapeutic cosmetic process for the whitening of the skin and / or mucous membranes and a whitening agent for the keratinous substances and / or a cosmetic or dermatological process for keratinous substances, which comprises the step of oral administration or topical application of the CB1 receptor antagonist to the skin and / And a method for selecting an anti-browning agent. |
| priorityDate |
2011-08-05^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |